Resiliency and Relentlessness are Crucial for Raising Medtech Capital: Interview with Beverly Huss, President and CEO of Qool Therapeutics

Resiliency and Relentlessness are Crucial for Raising Medtech Capital: Interview with Beverly Huss, President and CEO of Qool Therapeutics

vor 6 Jahren
49 Minuten
0
0 0 0
Podcast
Podcaster
Learn from proven medtech and healthtech experts. That's our primary goal with Medsider. Through uncut interviews with the world's brightest thought leaders, you'll pick up on helpful insights, lessons learned, best practices, and much more.

Beschreibung

vor 6 Jahren

Joining Medsider Radio for this episode is Beverly Huss,
President and CEO of Qool Therapeutics, a development-stage
company working on a novel, non-invasive therapeutic hypothermia
device for the preservation of tissue following catastrophic
events like a heart attack, stroke, or traumatic brain injury.


Previously, Beverly was the CEO of Vibrynt, a start-up medical
device company dedicated to creating minimally invasive therapies
for patients suffering from morbid obesity. Prior to that,
Beverly was the President of Guidant Endovascular Solutions
(acquired by Abbott), a medical device company focused on the
treatment of cardiovascular and peripheral vascular disease.


She holds an M.S. in technology management from Pepperdine
University, as well as a B.S. in metallurgical engineering from
the University of Illinois. Beverly also has a few patents to her
credit in the cardiovascular and obesity medical device arenas.


With me on this episode is guest host, Norbert Juist, one of the
most honest, genuine, and personable people I know. Norbert runs
Sales Performance Resources, where he specializes in recruiting
for medtech marketing and sales positions. Prior to this, he was
a sales rep at Cordis Endovascular, a spine consultant at
Synthes, and a sales rep at Ethicon. 


Interview Highlights with Beverly Huss


The origin story of Qool Therapeutics and how Beverly got
involved with the company.

The clinical trial strategy that Qool Therapeutics is
following and the reasoning for it.

Beverly’s strategic approach to making a medical device a
reality, including the regulatory, clinical, and reimbursement
paths that should be considered.

Key learnings from Beverly’s time at Vibrynt. 

The “other R&R”: the importance of resilience and
relentlessness when you are raising money for a company.

How to get the attention of medical device venture
capitalists.

Critical lessons Beverly throughout her career at ACS and
Guidant.

Beverly’s favorite books and how they inspire resiliency.

The business leaders and mentors that Beverly most admires.

Advice Beverly would give to her 30-year old self.



See more...
15
15
Close